Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma
- 14 August 2007
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 47 (5), 684-690
- https://doi.org/10.1016/j.jhep.2007.06.019
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular CarcinomaAnnals of Surgery, 2007
- Peg‐interferon improves liver histology in patients with HBeAg‐positive chronic hepatitis B: no additional benefit of combination with lamivudineLiver International, 2006
- Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trialZeitschrift für Krebsforschung und Klinische Onkologie, 2006
- Randomized clinical trial of the effects of abdominal drainage after elective hepatectomy using the crushing clamp methodBritish Journal of Surgery, 2006
- Candidates for therapy: HBVJournal of Hepatology, 2005
- Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experienceEuropean Journal of Surgical Oncology, 2005
- Therapeutic targeting of the tumor microenvironmentCancer Cell, 2005
- High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutationsInternational Journal of Cancer, 2004
- A decade?s studies on metastasis of hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosisThe Esophagus, 2003